cancer, cancer research, cell-free dna, new discoveries, research

Blood Test Can Predict Prognosis in Deadly Brain Cancer Glioblastoma

A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream — called a liquid biopsy — correlates with how patients will progress after they are diagnosed with glioblastoma (GBM). This is the deadliest and most common primary brain tumor in adults. In a new study, researchers from the Abramson Cancer Center ...

Troy Oakes

Drawing a blood sample.